7 research outputs found
The End of the Exceptional Financing of Erythropoiesis-Stimulating Agents in French Hospitals: What are the Impacts For Public Hospitals of Paris ?
A Long War Begins: Biosimilars Versus Patented Biologics – A Retrospective Analysis Of The Eu-5 And Japanese Erythropoetins Markets
ISPOR 19th Annual International Meeting Research AbstractsInternational audienc